T-cell responses to tumor-associated antigens, particularly those specific for the so-called universal tumor associated antigens (TAAs) survivin and telomerase, may be detected in the blood of patients with various types of cancer, even in early phases of the disease (30–33). Here, BIRC5 is linked to cancer.